Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML is a research paper published in Antibody Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: TL1TR003169
National Cancer Institute
Grant: R01CA248736
National Cancer Institute
Grant: R01CA263079
Department of Defense
Grant: ME190050
Cancer Prevention and Research Institute of Texas
Grant: RP220032
Cancer Prevention and Research Institute of Texas
Grant: RP150551
Welch Foundation
Grant: AU-0042-20030616
Immune-Onc Therapeutics, Inc.
Grant: #111077
NIAID NIH HHS
Grant: T32 AI005284
National Institutes of Health
Grant: 1R01CA263079-01A1
Reprogramming myeloid cells to inhibit cancer development
National Institutes of Health
Grant: 1R01CA248736-01
ITIM-receptors for cancer treatment
National Institutes of Health
Grant: 5TL1TR003169-02
NRSA Training Core
National Institutes of Health
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals